Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
2018
Northpond Ventures is a multi-billion dollar science-driven venture capital firm based in Cambridge, MA; San Francisco, CA; and Bethesda, MD. The firm is deeply engaged in the academic ecosystem, having founded: ✅ The Laboratory for Bioengineering Research and Innovation at Harvard’s Wyss Institute, the Institute’s first research and innovation alliance ✅ The MIT-Northpond Program, created to advance innovation in engineering and life sciences ✅ The Northpond Laboratories – Program for Research and Innovation at Stanford Medicine, which seeks to accelerate the pace of translation between scientific research to clinical and commercial applications through the vehicle of entrepreneurship Northpond Ventures has led or co-led 60+ financings over the past several years, and sits on the board of the vast majority of these businesses. Learn more at npv.vc.
2024
Behind every pioneering idea, method, and device is a fellow human or humans. A trailblazer who is daring enough to ask the questions that push boundaries and make the impossible possible. On Innovate and Elevate, we have candid, in-depth conversations from top doctors, scientists, leaders, and innovators on how they are trailblazing within the world at large and within their own lives. Season One of Innovate and Elevate focuses on women’s health with the aim of helping women lead our healthiest lives. Tune in wherever you listen to podcasts. Podcast Guests Include: ✅ Dr. Kathy Rexrode, Chief, Division of Women’s Health at Harvard’s Brigham Hospital ✅ Dr. Janet Storella, Medical Director, Breastlink Maryland at RadNet ✅ Dr. Rachel Brem, Director, Breast Imaging at George Washington University Hospital ✅ Dr. Canan Dağdeviren, Director of Conformable Decoders, Associate Professor at MIT
2019
2019
2019
2019
2002 - 2017
2002 - 2017
Led key areas over 15 year tenure (Analyst/PM for tech sector, Western States client relations, CFO), during which the firm grew assets over 30x from $1.5 billion to $50 billion.
1999 - 2002
1999 - 2002
1995 - 1997
1995 - 1997